Active Implantable Medical Devices Market: Size, Growth, Regional Analysis, And Market Analysis

Active Implantable Medical Devices:

Active Implantable Medical Devices are widely utilized in the medical sector for diagnostic and therapeutic purposes, and they are implanted wholly or partially in the human body. The device will be embedded in the patient's body and will remain there permanently. Cardiovascular machines, Parkinson's disease, epilepsy, spasticity, and people with hearing or vision impairment are among the conditions for which active implanted medical devices are used.

These devices can track, drive, and control cardiac rhythms, monitor hypertension, deliver functional electrical stimulation to nerves, detect glaucoma, and measure bladder and cranial pressure. Pacemakers, defibrillators, infusion pumps, ventricular assist systems and devices, cochlear implants, and neurostimulators are among the product lines and types.

Market Growth:

The Active Implantable Medical Devices Market is expected to reach $27.7 billion by 2025, with a compound annual growth rate (CAGR) of 7.9% from 2020 to 2025.

The primary growth drivers for the implantable and life-sustaining devices market are the aging population, rising prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favorable reimbursement scenarios ENT procedures in developed countries. However, adverse healthcare reforms in the United States concern the use of implantable medical devices, and the high cost of implants may limit the market's growth.

Factors such as an increase in cardiovascular and neurological cases, an increase in the number of children who require these devices, new advances in procedures, and an increase in the use of implantable devices in neurological illnesses are all contributing to this trend.

Implantable cardioverter-defibrillators, implanted cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and implantable hearing devices are the product segments of the market.

Regional Analysis:

North America, Europe, Asia-Pacific, the Middle East, and the Rest of the World make up the Active Implantable Medical Devices Market. In terms of sales, North America dominated, accounting for 39.8% of the total in 2019. This is due to the region's growing demand for innovative and technologically advanced products and rising healthcare spending. However, during the projected 2020-2025, Asia Pacific is expected to have the highest CAGR. This is due to an increase in cardiovascular and neurological illnesses in Asian countries, which is propelling the Asia Pacific Implantable Medical Devices Market forward.

Key Players:

William Demant Holding A/S, Nurotron Biotechnology Co. Ltd, MED-EL Medical Electronics, Medtronic Plc, LivaNova PLC, Sonova Holding AG, Cochlear Ltd, Boston Scientific, Corporation, BIOTRONIK SE & Co. KG, and Abbott Laboratories are the major key players of Active Implantable Medical Devices Market.